Circadin(R) - Prolonged Release Melatonin for Primary Insomnia is Licensed to
Sigma Pharmaceuticals for Australia Markets
Circadin(R), currently approved for use in 33 countries, is a novel sleep aid indicated for treatment of primary insomnia. The latest approval in
Sigma Pharmaceuticals Ltd. will launch Circadin(R) in
"Circadin(R) is the first and only approved melatonin based ethical drug" says
"Circadin(R), an IP protected formulation which essentially mimics the normal nocturnal melatonin profile, improves sleep quality and morning alertness and facilitates sleep onset, is a very valuable alternative to traditional sedative hypnotics. Most other sleep aids share a number of drawbacks, such as dependency, amnesia and residual drowsiness, unlike Circadin(R)," says
"We are pleased to license Circadin(R) and introduce a new class treatment for insomnia into
There are plans in place to register Circadin(R) in the
About Circadin(R)
Circadin(R) (http://www.Circadin.info) is the first and only IP-protected prolonged-release melatonin and the first and only melatonin product to be approved as an ethical drug by health authorities. In clinical trials involving thousand of patients with primary insomnia, it has been demonstrated that administration of Circadin(R) improves sleep quality and morning alertness and facilitates sleep onset in patients aged 55 or over. Currently approved for commercialization in 33 countries, Circadin(R) is undergoing plans for registration in
About Neurim Pharmaceuticals
Neurim Pharmaceuticals (http://www.neurim.com) is based in
About Sigma Pharmaceuticals
Sigma Pharmaceuticals Limited (ASX:SIP) is a leading Australian manufacturer, wholesaler and distributor of prescription, over-the-counter and generic pharmaceutical products to pharmacies throughout
For further information: For further information: Eran Schenker, MD, Medical Director & Corporate Business Development, Neurim Pharmaceuticals Ltd., Tel: +972-3-7684914, Cell: +972-52-6689944, [email protected], OR Elmo de Alwis, Managing Director, Sigma Pharmaceuticals Limited, Tel: +61-(0)3-9839-2820, [email protected]
Share this article